Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 26, 2023 Category: Cancer & Oncology Authors: Tianlei Qiu Guoshuang Shen Yuanfang Xin Jinming Li Yonghui Zheng Zijun Zhu Chengrong Zhang Yuyao Tang Miaozhou Wang Zhen Liu Yi Zhao Fuxing Zhao Dengfeng Ren Huihui Li Yaobang Liu Xinlan Liu Jiuda Zhao Source Type: research
Evaluation of progression-free survival as a surrogate end point in primary CNS lymphoma: a systematic review and meta-analysis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 26, 2023 Category: Cancer & Oncology Authors: Jing Zhan Shijie Yang Wei Zhang Daobin Zhou Danqing Zhao Yan Zhang Wei Wang Chong Wei Source Type: research
Current stand on systemic therapy in localized soft tissue sarcomas: a clinician's perspective
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 20, 2023 Category: Cancer & Oncology Authors: Archana Sasi Sameer Rastogi Source Type: research
Erratum
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 20, 2023 Category: Cancer & Oncology Source Type: research
Cetuximab every 2 weeks versus standard weekly dosing administration schedule
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 18, 2023 Category: Cancer & Oncology Authors: Carsten Bokemeyer Fortunato Ciardiello Olivier Dubreuil Joel Guigay Stefan Kasper Per Pfeiffer Carmine Pinto Kensei Yamaguchi Takayuki Yoshino Christoph Zielinski Regina Esser Josep Tabernero Source Type: research
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 13, 2023 Category: Cancer & Oncology Authors: Johanna Vikkula Kristiina Uusi-Rauva Tuuli Ranki Iiro Toppila Maria Aalto-Set älä Katariina Pousar Lotta Vassilev Kimmo Porkka Raija Silvennoinen Oscar Br ück Source Type: research
Real-world utilization of lenvatinib and pembrolizumab combination therapy for the treatment of endometrial cancer in the USA
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 13, 2023 Category: Cancer & Oncology Authors: Keiko Wada Jingchuan Zhang Inyoung Lee Yi Wang Aimee Near Vimalanand S Prabhu Source Type: research
siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 12, 2023 Category: Cancer & Oncology Authors: Yanling Yu Dimitri Papukashvili Ruimin Ren Nino Rcheulishvili Shunping Feng Wenqi Bai Huanhu Zhang Yanfeng Xi Xiaoqing Lu Nianzeng Xing Source Type: research
Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 10, 2023 Category: Cancer & Oncology Authors: Charles Dharmani Sudhir Unni Ngan Pham Nazneen Fatima Shaikh Yan Xiong Rohan Vashi Oluwatosin Fofah Alessandria Strubing Maribel Salas Nora Tu Margaret Wooddell Xiaoyu Zhou Aimee Near Source Type: research
Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease: CAMCO trial
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 10, 2023 Category: Cancer & Oncology Authors: Jiayu Ling Ziqin Lin Lishuo Shi Yan Lin Xin Liu Junyan Lin Jianxia Li Jianwei Zhang Huabin Hu Yue Cai Yanhong Deng Source Type: research
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 10, 2023 Category: Cancer & Oncology Authors: Elena Elez Scott Kopetz Josep Tabernero Tanios Bekaii-Saab Julien Taieb Takayuki Yoshino Gulam Manji Kathrine Fernandez Antonello Abbattista Xiaosong Zhang Van K Morris Source Type: research
In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 9, 2023 Category: Cancer & Oncology Authors: Robert M Rifkin Caitlin L Costello Ruemu E Birhiray Suman Kambhampati Joshua Richter Rafat Abonour Hans C Lee Michael Stokes Kaili Ren Dawn Marie Stull Dasha Cherepanov Kimberly Bogard Stephen J Noga Saulius Girnius Source Type: research
Prognostic significance of the systemic inflammation response index in gastrointestinal malignancy patients: a pooled analysis of 10,091 participants
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 6, 2023 Category: Cancer & Oncology Authors: Xian-Wen Liang Bing Liu Hai-Jing Yu Jia-Cheng Chen Zhi Cao Sheng-Zhong Wang Jin-Cai Wu Source Type: research
Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 5, 2023 Category: Cancer & Oncology Authors: Georges Ayoub Hassan Sinan Hampig Raphael Kourie Joseph Kattan Fadi Nasr Fadi el Karak Jad Wakim Marwan Ghosn Georges Chahine Chantal Farra Alain Chebly Source Type: research
As a potential predictor of pan-cancer, UBE2S is related to tumor-associated macrophage infiltration
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 4, 2023 Category: Cancer & Oncology Authors: Haodi Yue Jialin Wang Siyu Hou Mengjun Zhang Source Type: research
